Compounds > 1-phenyl-2-decanoylamino-3-morpholino-1-propanol

1-phenyl-2-decanoylamino-3-morpholino-1-propanol and osteoprotegerin

1-phenyl-2-decanoylamino-3-morpholino-1-propanol has been researched along with osteoprotegerin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fukumoto, E; Fukumoto, S; Hasegawa, T; Iwamoto, T; Kato, Y; Nonaka, K; Sakai, E; Yamada, A; Yuasa, K	1

Reviews

1 review(s) available for 1-phenyl-2-decanoylamino-3-morpholino-1-propanol and osteoprotegerin

Article	Year
Current topics in pharmacological research on bone metabolism: osteoclast differentiation regulated by glycosphingolipids. Journal of pharmacological sciences, 2006, Volume: 100, Issue:3 Topics: Animals; Antigens, CD; Bone and Bones; Carrier Proteins; Cell Differentiation; Cells, Cultured; Enzyme Inhibitors; Glucosyltransferases; Glycoproteins; Glycosphingolipids; Humans; Lactosylceramides; Membrane Glycoproteins; Membrane Microdomains; Morpholines; Osteoclasts; Osteoprotegerin; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Signal Transduction	2006

Article

Year

Current topics in pharmacological research on bone metabolism: osteoclast differentiation regulated by glycosphingolipids.

Journal of pharmacological sciences, 2006, Volume: 100, Issue:3

Topics: Animals; Antigens, CD; Bone and Bones; Carrier Proteins; Cell Differentiation; Cells, Cultured; Enzyme Inhibitors; Glucosyltransferases; Glycoproteins; Glycosphingolipids; Humans; Lactosylceramides; Membrane Glycoproteins; Membrane Microdomains; Morpholines; Osteoclasts; Osteoprotegerin; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Signal Transduction

2006